Eric A. Macklin

14.9k total citations · 2 hit papers
205 papers, 9.1k citations indexed

About

Eric A. Macklin is a scholar working on Neurology, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Eric A. Macklin has authored 205 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Neurology, 43 papers in Psychiatry and Mental health and 35 papers in Genetics. Recurrent topics in Eric A. Macklin's work include Amyotrophic Lateral Sclerosis Research (27 papers), Autism Spectrum Disorder Research (23 papers) and Parkinson's Disease Mechanisms and Treatments (21 papers). Eric A. Macklin is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (27 papers), Autism Spectrum Disorder Research (23 papers) and Parkinson's Disease Mechanisms and Treatments (21 papers). Eric A. Macklin collaborates with scholars based in United States, Canada and United Kingdom. Eric A. Macklin's co-authors include James S. Clark, Leslie Wood, Janneke HilleRisLambers, Miles R. Silman, Melody J. Cunningham, Ellis J. Neufeld, Alan R. Cohen, Michael R. DeBaun, Peter M. Wayne and Merit Cudkowicz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Eric A. Macklin

201 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SEED DISPERSAL NEAR AND FAR: PATTERNS ACROSS TEMPERATE AND TROPICAL FORESTS

1999 708 citations Eric A. Macklin et al. profile →
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

2013 492 citations Eric A. Macklin, Richard Smith et al. profile →

Peers

Countries citing papers authored by Eric A. Macklin

Since Specialization

Citations

This map shows the geographic impact of Eric A. Macklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Macklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Macklin more than expected).

Fields of papers citing papers by Eric A. Macklin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Macklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Macklin. The network helps show where Eric A. Macklin may publish in the future.

Co-authorship network of co-authors of Eric A. Macklin

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Macklin. A scholar is included among the top collaborators of Eric A. Macklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Macklin. Eric A. Macklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort 2025 ·EBioMedicine ·(unknown), Xinyuan Zhang, Eric A. Macklin, Jian Wang, Armin Bayati, Johannes M. Dijkstra, Hirohisa Watanabe, Michael A. Schwarzschild, Marianna Cortese, Xuehong Zhang, (unknown)	0
2	Promoting Physical Activity in People With Parkinson’s Disease Through a Smartphone App: A Pilot Study 2025 ·Journal of Neurologic Physical Therapy ·Sabine Schootemeijer, Nienke M. de Vries, Sirwan K.L. Darweesh, Alberto Ascherio, Michael A. Schwarzschild, Eric A. Macklin, Bastiaan R. Bloem	5
3	Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis 2024 ·EBioMedicine ·Michael Benatar, Eric A. Macklin, Andrea Malaspina, Mary‐Louise Rogers, Eran Hornstein, Vittoria Lombardi, (unknown), Stephanie Shepheard, Iddo Magen, (unknown), Volkan Granit, Jeffrey Statland, Jeannine M. Heckmann, Rosa Rademakers, Caroline McHutchison, Leonard Petrucelli, Corey T. McMillan, Joanne Wuu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	14
4	Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results 2023 ·Parkinsonism & Related Disorders ·Hubert H. Fernandez, Eric A. Macklin, Robert A. Hauser, Kelvin L. Chou, Yusuf Özgür Çakmak, (unknown), Stanley Fahn	2
5	Enrollment of Participants From Marginalized Racial and Ethnic Groups 2023 ·Neurology Clinical Practice ·Daniel G. Di Luca, Eric A. Macklin, (unknown), (unknown), Lindsay Pothier, (unknown), (unknown), James Chan, Aleksandar Videnović, Codrin Lungu, Anthony E. Lang, Irene Litvan, Michael A. Schwarzschild, T. Simuni	7
6	A Mind-Body Physical Activity Program for Chronic Pain With or Without a Digital Monitoring Device: Proof-of-Concept Feasibility Randomized Controlled Trial 2020 ·JMIR Formative Research ·Jonathan Greenberg, Paula Popok, Ann Lin, Ronald J. Kulich, Peter James, Eric A. Macklin, Rachel Millstein, Robert R. Edwards, Ana‐Maria Vranceanu	47
7	A Live Video Mind-Body Treatment to Prevent Persistent Symptoms Following Mild Traumatic Brain Injury: Protocol for a Mixed Methods Study 2020 ·JMIR Research Protocols ·Jonathan Greenberg, (unknown), Grant L. Iverson, Noah D. Silverberg, Eric A. Macklin, Robert A. Parker, Joseph T. Giacino, Gloria Y. Yeh, Ana‐Maria Vranceanu	14
8	Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial 2019 ·Neurology ·Michael A. Schwarzschild, Eric A. Macklin, Rachit Bakshi, (unknown), Robert Logan, Alberto J. Espay, Albert Y. Hung, Grace Bwala, Christopher G. Goetz, David Russell, John L. Goudreau, Sotirios A. Parashos, Marie Saint‐Hilaire, Alice Rudolph, Joshua M. Hare, Gary C. Curhan, Alberto Ascherio, (unknown)	34
9	General Characteristics of edaravone Use in the Natural History of ALS and Other Motor Neuron Disorders Consortium Dataset (NeuroBANK ^™ ) (S5.006) 2019 ·Neurology ·Ximena Arcila-Londono, David Walk, Scott Vota, Alexander Sherman, Kimberly Goslin, Ghazala Hayat, Christian Lunetta, Daniel S. Newman, (unknown), James Wymer, Nicholas Olney, (unknown), Hong Yu, Lucia Alvarado, (unknown), (unknown), (unknown), (unknown), Francesca Gerardi, Eric A. Macklin	1
10	Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self‐report scale (Center for Neurologic Study Bulbar Function Scale) 2018 ·European Journal of Neurology ·Richard Smith, Eric A. Macklin, Kathleen Myers, Gary L. Pattee, Kimberly Goslin, Gregg Meekins, (unknown), Jeremy M. Shefner, Erik P. Pioro	31
11	Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial 2018 ·JMIR Research Protocols ·Ana‐Maria Vranceanu, Emily L. Zale, (unknown), Eric A. Macklin, Jessica L. McCurley, Elyse R. Park, Justin T. Jordan, Ann Lin, Scott R. Plotkin	29
12	Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use 2018 ·Journal of Child and Adolescent Psychopharmacology ·Michael G. Aman, Jill A. Hollway, Jeremy Veenstra‐VanderWeele, Benjamin L. Handen, Kevin Sanders, James Chan, Eric A. Macklin, L. Eugene Arnold, (unknown), Cassandra R. Newsom, (unknown), Sarah Marler, (unknown), Evdokia Anagnostou	10
13	The facial morphology in Down syndrome: A 3D comparison of patients with and without obstructive sleep apnea 2017 ·American Journal of Medical Genetics Part A ·Yasas S. N. Jayaratne, (unknown), Eric A. Macklin, (unknown), Gil S. Weintraub, Dennis Rosen, Brian G. Skotko	19
14	Family perspectives about Down syndrome 2015 ·American Journal of Medical Genetics Part A ·Brian G. Skotko, Susan P. Levine, Eric A. Macklin, Richard D. Goldstein	28
15	Sulforaphane treatment of autism spectrum disorder (ASD) 2014 ·Proceedings of the National Academy of Sciences ·Kanwaljit Singh, Susan L. Connors, Eric A. Macklin, Kirby D. Smith, Jed W. Fahey, Paul Talalay, Andrew W. Zimmerman	338
16	Oral Inosine Persistently Elevates Plasma Antioxidant Capacity in Early Parkinson’s Disease (S37.009) 2014 ·Neurology ·Shamik Bhattacharyya, Rachit Bakshi, Robert Logan, Alberto Ascherio, Eric A. Macklin, Michael A. Schwarzschild	1
17	Post-lumbar puncture headache is reduced with use of atraumatic needles in ALS 2013 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Colin Quinn, Eric A. Macklin, Nazem Atassi, Robert Bowser, Khrista Boylan, Merit Cudkowicz, Christina Fournier, Shafeeq Ladha, David Lacomis, James D. Berry	5
18	Deficiency of HIV-Gag-Specific T Cells in Early Childhood Correlates with Poor Viral Containment 2008 ·The Journal of Immunology ·Sihong Huang, (unknown), Yanhua Tang, Eric A. Macklin, (unknown), (unknown), (unknown), (unknown), Bruce D. Walker, C D C Christie, Margaret E. Feeney	31
19	Correlated Change in Upper Limb Function and Motor Cortex Activation After Verum and Sham Acupuncture in Patients with Chronic Stroke 2007 ·The Journal of Alternative and Complementary Medicine ·Judith D. Schaechter, (unknown), William B. Stason, Ted J. Kaptchuk, David E. Krebs, Eric A. Macklin, Rosa N. Schnyer, Joel Stein, Donna Moxley Scarborough, Stephen W. Parker, Chris A. McGibbon, Peter M. Wayne	68
20	アルコール中毒のテトラエチールサイユラムヂサルファイド(アンタブス(R))による心血管障碍 1951 ·JAMA ·Eric A. Macklin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact